NIHR (National Institute for Health and Care Research)

A major new trial will test the efficacy of a new therapy for a disabling post-stroke condition that affects around 1 in 3 survivors. The study is being funded by a partnership between NIHR (National Institute for Health and Care Research) and Medical Research Council and led by researchers at University of East Anglia . There are 1.3 million stroke survivors in the UK, with an estimated 390,000 of those suffering from spatial inattention, for which there is currently no effective treatment. People affected by it often have poor recovery and long-term disability. However, a new therapy called SIGHT (Spatial Inattention Grasping Therapy) has showed promise in improving the condition. This trial will take a closer look at its effectiveness. https://lnkd.in/eve5DRth #WorldStrokeDay2024 #SpatialInattention

Do you want to get involved in reviewing research or improve your skills in writing funding applications? Our training course for reviewing has recently been revamped and covers reviewing in all contexts for NIHR research funding programmes, plus skills and activities required at different levels and stages of research. This is a fantastic tool to understand how to get your patient and public involvement right the first time. Learn more about the course here ⬇️ https://lnkd.in/eAttTjcw

Want to make your application stand out? Generic statements that lack clarity and fail to show a true understanding of your proposal can hurt your chances. Check out top tips in the Chair’s Report from the last DLAF round to see what makes a competitive application: 👇https://lnkd.in/eSQ5pPTP Haven’t started your application yet? There’s still time! Applications close December 5, 2024. ⏰

We’ve published our annual report and accounts, showcasing key milestones and successes achieved throughout the 2023/24 financial year. Some of these successes include: 🗞️ An innovative £42m prostate cancer screening trial, co-funded by us and @Prostate Cancer UK to find ways of detecting the country’s most common male cancer earlier. 🗞️ Our research invests in foundational underpinning science, facilities, talent and capacity building across the health and care workforce which makes the country and science superpower. Our Clinical Research Network supported the recruitment of 44 first participants to global studies, and to 558 commercial international studies overall in 2023/24, representing an increase in both measures compared to 2022/23. 🗞️ In 2023/24 we launched our first NIHR ‘Challenge’ funding call, investing £50 million into research to tackle inequalities in maternity care. 🗞️ Following the results from an NIHR-funded study, the UK Government has approved the use of digital pathology to help speed up analysis of cancer screening samples. Read the full news story below: https://lnkd.in/eUWBaZVE #AnnualReport

Catch up on the third and final event of this year's national #ARCseminar series exploring health inequalities research from across our NIHR Applied Research Collaborations (ARCs) #NIHRARCs. https://lnkd.in/eMMXm2z4 Over 380 people joined live for the 10 July 2024 national ARCs webinar on regional health inequalities. Three short talks covered research on health inequalities between English regions. This webinar was chaired by Prof Monique Lhussier of NIHR Applied Research Collaboration (ARC) North East and North Cumbria (NENC) Talk 1: Dr Luke Munford of NIHR ARC Greater Manchester on place-based health inequalities in England. Talk 2: Prof Kate Pickett, OBE NIHR ARC Yorkshire and Humber on regional health inequalities for children, young people and women Talk 3: Prof Nisreen Alwan, MBE of @nihr-arc-wessex on predicting childhood obesity and links to food insecurity in the UK

Take a look at our NEW funding opportunities! - NIHR Doctoral Fellowship Round 13 - NIHR Advanced Fellowship - Australia-UK platform studies in areas of unmet clinical need For more details and to apply, please see: https://lnkd.in/eqadvf2b

We’re looking for a leader to join our Health Technology Assessment (HTA) programme as Chair of one of our HTA Prioritisation Committees. The HTA Programme is currently the largest of our NIHR programmes and recently celebrated its 30th anniversary. As Chair for this committee, you will: ➡️ review research topics relevant to hospital based and specialist care ➡️ engage all members of the committee in discussion ➡️ ensuring clear decisions are made ➡️ supporting the Strategic Commissioning team in the identification and development of potential topics The successful candidate will have enthusiasm for and experience of evidence-based practice (in a senior clinical role in the NHS). They will have excellent communication skills, proven ability to chair large committees effectively, and a track record of research leadership. Learn more about this exciting opportunity and apply here: https://lnkd.in/ejMDY5DD

We're working with James Lind Alliance to make sure that the most important research questions are answered. Take a look at their latest Top 10 priorities for menopause research and apply for #ResearchFunding here: https://lnkd.in/etHyhv5N 

Today with the Department of Health and Social Care, we've announced £80 million for research to protect the public from #HealthThreats ⚠️ £77 million of this funding is being allocated to 13 NIHR Health Protection Research Units (HPRUs) which are partnerships between UK universities and the UK Health Security Agency. Since 2014, the HPRUs have been vital in supporting the health response to major domestic and global emergencies. This latest round includes funding for HPRUs focusing on: 🧫 Healthcare Associated Infections and Antimicrobial Resistance ☀️ Climate Change and Health Security 🦇 Emerging Zoonoses 🚨 Emergency Preparedness and Response In addition, £3 million of the funding is being made through two Health Protection Research Focus Awards on: 💉 Vaccines and Immunisation 🦺 Emergency Preparedness and Response To find out more, visit 👉 https://lnkd.in/e9ibE3R4 Lucy Chappell

Did you know before 2013, there were no vaccines to protect against Meningitis B, a leading infectious killer among young children? Dr Hannah Christensen’s influential work critically informed the roll out of a life-saving vaccine to protect children under 5. Supported by multiple NIHR career development awards, Dr Christensen alongside her team developed models that led to the rollout of a life-saving MenB vaccine for babies, with projected reduction of cases by over 25% in 5 years. Her work not only saved lives but also saved the NHS, Department of Health and Social Care £136 million annually. Read our latest #MakingADifference #Impact story 👇 https://lnkd.in/eyqDaUD6 #Health #Care #Research University of Bristol